Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Expression of Serum Angiogenesis Marker in Patients Presenting With Hemoptysis

NCT01171768 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT01171768
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01171768 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Expression of Serum Angiogenesis Marker in Patients Presenting With Hemoptysis
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Completed
Start date
June 30, 2008
Completion date
December 31, 2010
Enrollment
52 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hemoptysis, inflammatory lung diseases